Chemotherapy tolerance and continuity are prognostic for overall survival in patients with localized and advanced biliary tract cancer
This study shows that a significant proportion of patients with BTC are not eligible or intolerant to chemotherapy in the real world. Maintaining the planned treatment, even with dose reduction, is associated with better OS.
Authors
- Elif Berna Köksoy (ORCID: https://orcid.org/0000-0002-6590-4444)
- Erman Akkuş (ORCID: https://orcid.org/0000-0002-7531-7817)
- Arzu Yaşar (ORCID: https://orcid.org/0000-0002-0545-1383)
- PINAR KUBİLAY TOLUNAY
Institutions
- Ankara University (TR)
Publication Details
- Journal
- TURKISH JOURNAL OF MEDICAL SCIENCES
- Published
- 2025-12-12
- DOI
- https://doi.org/10.55730/1300-0144.6102
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00